Papers by James P. Allison
Page 5 · newest first
- Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancerSHILAP Revista de lepidopterología · 2017
- Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignanciesJournal for ImmunoTherapy of Cancer · 2017
- Genomic and immune heterogeneity are associated with differential responses to therapy in melanomanpj Genomic Medicine · 2017
- Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistanceScience Translational Medicine · 2017
- Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunityNature Communications · 2017
- Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 BlockadeCancer Immunology Research · 2017
- Nivolumab Combined with Ibrutinib for CLL and Richter Transformation: A Phase II TrialBlood · 2016
- Phase IB/II Study of Nivolumab in Combination with Azacytidine (AZA) in Patients (pts) with Relapsed Acute Myeloid Leukemia (AML)Blood · 2016
- Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by RadiotherapyCancer Research · 2016
- Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicitiesProceedings of the National Academy of Sciences · 2016
- Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case reportJournal of Hematology & Oncology · 2016
- Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after ImmunotherapyCancer Immunology Research · 2016
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activitySHILAP Revista de lepidopterología · 2016
- A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune ProfilingClinical Cancer Research · 2016
- Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapyNature Communications · 2016
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint BlockadeCancer Discovery · 2016
- ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40–Mediated Tumor RejectionCancer Research · 2016
- De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research InstituteCancer Immunology Research · 2016
- Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanomaOncoImmunology · 2016
- Pilot study of intratumoral (IT) cryoablation (cryo) in combination with systemic checkpoint blockade in patients with metastatic melanoma (MM)Journal for ImmunoTherapy of Cancer · 2015
- Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent MannerSHILAP Revista de lepidopterología · 2015
- Immune Checkpoint Blockade in Cancer Therapy: The 2015 Lasker-DeBakey Clinical Medical Research Award.2015
- Unique potential of 4-1BB agonist antibody to promote durable regression of HPV ⁺ tumors when combined with an E6/E7 peptide vaccineProceedings of the National Academy of Sciences · 2015
- Strategies for Combining Immunotherapy with Radiation for Anticancer TherapyImmunotherapy · 2015
- Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate CancerCancer Immunology Research · 2015
- Co-occurring Genomic Alterations Define Major Subsets of KRAS -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic VulnerabilitiesCancer Discovery · 2015
- The future of immune checkpoint therapyScience · 2015
- B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethalityBlood · 2015
- Friends Not Foes: CTLA-4 Blockade and mTOR Inhibition Cooperate during CD8+ T Cell Priming To Promote Memory Formation and Metabolic ReadinessThe Journal of Immunology · 2015
- Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)Journal for ImmunoTherapy of Cancer · 2014
- Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?Cancer Immunology Research · 2014
- Cytotoxic T Lymphocyte Antigen-4 Blockade Enhances Antitumor Immunity by Stimulating Melanoma-Specific T-cell MotilityCancer Immunology Research · 2014
- Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapyThe Journal of Experimental Medicine · 2014
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade ImmunotherapyScience Translational Medicine · 2014
- Immune Modulation in Cancer with AntibodiesAnnual Review of Medicine · 2013
- Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4Journal for ImmunoTherapy of Cancer · 2013
- Prostate Cancer Progression Correlates with Increased Humoral Immune Response to a Human Endogenous Retrovirus GAG ProteinClinical Cancer Research · 2013
- Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma PatientsCancer Immunology Research · 2013
- Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 TherapyCancer Immunology Research · 2013
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanomaThe Journal of Experimental Medicine · 2013
- Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanomaAnnals of the New York Academy of Sciences · 2013
- Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4The Journal of Experimental Medicine · 2013
- Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of EomesoderminThe Journal of Experimental Medicine · 2013
- Aire-Dependent Thymic Development of Tumor-Associated Regulatory T CellsScience · 2013
- Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific LigandThe Journal of Immunology · 2012
- Cancer classification using the Immunoscore: a worldwide task forceJournal of Translational Medicine · 2012
- B7x in the Periphery Abrogates Pancreas-Specific Damage Mediated by Self-reactive CD8 T CellsThe Journal of Immunology · 2012
- Cutting Edge: CTLA-4 on Effector T Cells Inhibits In TransThe Journal of Immunology · 2012
- CTLA-4 blockade synergizes with cryoablation to mediate tumor rejectionOncoImmunology · 2012
- Augmented IL-15Rα Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in MiceThe Journal of Immunology · 2012